HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health (OTC Drugs)

Set Alert for Health (OTC Drugs)

Regulation/Legislation Explore this Topic

Set Alert for Regulation and Legislation {Health}

Latest From Regulation, Legislation & Health

Perrigo Steers Through Transportation Obstacles, Soaring Shipping Costs From COVID-19

Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.

Coronavirus COVID-19 M & A

Califf Clears First Senate Hurdle, But FDA Decision On Abortion Pill May Complicate Final Confirmation

Republican opposition to Califf over agency’s recent move to relax its Mifeprex restrictions is ominous since, in order be confirmed as commissioner, he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to pharma industry.

FDA Leadership

Government Skepticism And Over Regulation Holding Back Self-Care In France – GSCF Analysis

France's self-medication market lags behind its European rivals. Why is that? A skeptical and over-cautious government and a stifling regulatory system may provide at least part of the answer, the Global Self-Care Federation's recently published Self-Care Readiness Index suggests.  

France Health

France ‘Not Receptive’ To Self-Care, But Wellness And E-Commerce Trends Are Driving Change

Regulatory barriers, government conservativism and a generous reimbursement system have all held back the development of France's self-care market. However, executive director of the French self-care industry association, Luc Besançon, thinks that the growing trends for prevention and e-commerce will change this in the future. 

France Health

Consider Environmental Risks During OTC Reclassification, Says Sweden's Drugs Regulator

Sweden's national drugs regulator says environmental contamination risks should be reviewed as part of the overall benefit/risk assessment when reclassifying OTCs for sale outside pharmacies.

Sweden Regulation

PCPC, CHPA Ask US FDA To Defer Final Rulemaking On Sunscreen Actives In GRASE Limbo

Industry continues working to support updated GRASE findings for UV filters avobenzone, homosalate, octinoxate, octisalate, octocrylene, oxybenzone, ensulizole and meradimate, which the FDA categorized more than two years ago as lacking data, a position it reprised in 2021 under its overhauled OTC monograph system.

United States FDA
See All

Business Explore this Topic

Set Alert for Business {Health}

Latest From Deals & Health

GSK Rejects £50bn Bid For Consumer Healthcare From Unilever

GSK says London-based Unilever's £50bn bid for Consumer Healthcare fundamentally undervalues a business which generated sales close to £10bn last year and is expected to grow 4-6% over the medium term. The rejection has not dissuaded Unilever, however, with the company intent on stepping up its presence in the health, beauty and hygiene categories.

Deals Business Strategies

Perrigo Steers Through Transportation Obstacles, Soaring Shipping Costs From COVID-19

Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.

Coronavirus COVID-19 M & A

In Flip Of Bausch Health’s Planned Order For IPOs, Bausch + Lomb Registration Comes Before Solta

“We are positioned to move forward with either the Bausch + Lomb or Solta IPO quickly when market conditions are right for each of them,” CEO Joseph Papa says at J.P. Morgan conference, but the firm’s “next step” in the process of separating the two businesses was filing with the SEC an IPO registration for Bausch + Lomb.

M & A OTC Drugs
See All

Latest From Business Strategies & Health

GSK Rejects £50bn Bid For Consumer Healthcare From Unilever

GSK says London-based Unilever's £50bn bid for Consumer Healthcare fundamentally undervalues a business which generated sales close to £10bn last year and is expected to grow 4-6% over the medium term. The rejection has not dissuaded Unilever, however, with the company intent on stepping up its presence in the health, beauty and hygiene categories.

Deals Business Strategies

Perrigo Steers Through Transportation Obstacles, Soaring Shipping Costs From COVID-19

Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.

Coronavirus COVID-19 M & A

In Flip Of Bausch Health’s Planned Order For IPOs, Bausch + Lomb Registration Comes Before Solta

“We are positioned to move forward with either the Bausch + Lomb or Solta IPO quickly when market conditions are right for each of them,” CEO Joseph Papa says at J.P. Morgan conference, but the firm’s “next step” in the process of separating the two businesses was filing with the SEC an IPO registration for Bausch + Lomb.

M & A OTC Drugs
See All

Latest From Sales & Earnings & Health

Over The Counter 22 November 2021: CHC Spin Outs, Supply Chain Issues And Other Q3 Trends

In this episode, HBW Insight’s US and EU editors analyse Q3 OTC business trends, including why the biggest pharmaceutical companies in the world are spinning out their consumer health businesses to create new standalone firms and what's causing the supply chain troubles that are driving up OTC product prices.

International Health

EU Business News: Ceres Acquires GlobiFer Iron Supplement, PharmaSGP Achieves Record Quarter

The latest European consumer healthcare business news: Belgium's Ceres Pharma expands its portfolio with GlobiFer; and PharmaSGP achieves its best ever quarter thanks to the recovery of the OTC market.

Deals Sales & Earnings

Taisho's Strong Showing In Japan Offsets Lower Sales In Europe

Japan's Taisho reported higher sales in the six months ended 30 September as the continued recovery of the domestic OTC market offset a weaker performance overseas.

Sales & Earnings Japan
See All

Latest From Legal Issues & Health

US 2021 Consumer Health Fraud Headaches Include Securities Scam By ‘Fast-Acting Aspirin’ Firm

FDA worked on investigations with US Attorneys’ offices and other federal agencies of unlawful sales of supplements promoted to prevent or treat COVID-19 as well as other diseases and health conditions and of prescription drugs offered OTC for muscle growth or sexual enhancement.

Consumer Coronavirus COVID-19

Manchin’s Build Back Better Battle Could Sink Restoring FTC Monetary Relief Authority

Members of Congress in favor of giving FTC authority to impose monetary relief orders against firms linked to false advertising likely were caught off guard when West Virginia Democrat said he wouldn’t vote for legislation with $2.2 trillion for climate change, tax and social programs that President Biden made a primary plank of his Capitol Hill strategy and that the House passed in November.

Ad Complaints Consumer

P&G Among US Firms Asked To Explain How, Why Supply Chain Problems Cause Consumer Hardships

Procter & Gamble and Amazon are among nine companies FTC ordered to provide detailed information to help the agency identify causes behind ongoing supply chain disruptions. Chairwoman Khan says the information should “shed light on market conditions and business practices that may have worsened these disruptions.”

Coronavirus COVID-19 Consumer
See All

Marketing Explore this Topic

Set Alert for Marketing {Health}

Latest From Launches & Health

Health And Wellness Weekly Trademark Review 11 January, 2022

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements Trademarks

PLx Will More Prominently Disclose ‘Clinically Shown’ Claim Refers To Vazalore 325-mg Aspirin

BBB National Programs’ appeals panel agrees with National Advertising Division that PLx should modify TV ad to clearly and conspicuously disclose that “clinically shown to cause fewer ulcers than plain aspirin” refers to Vazalore 325 mg and not 81-mg dose.

Ad Complaints Enforcement

P&G Extends Oral-B Brush Line With iOSense

Brush “provides live coaching” through embedded iOSense Charger to guide time, pressure and coverage without needing to watch smartphone app. Firm also extending Oral-B iO lineup with lower-priced iO4 and iO5 brushes available nationwide in the US beginning later in 2022.

Business Strategies Launches
See All

Latest From Ad Campaigns & Health

Over The Counter 20 Dec 2021: Navigating The UK Green Claims Code, with PHD's Jo Stephenson

How can self-care companies operating in the UK avoid 'greenwashing' when making environmental claims for their brands? In this episode, HBW Insight speaks to PHD Marketing managing director Jo Stephenson about the new UK Green Claims Code, and how OTC firms can navigate this new guidance on making claims for 'eco-friendly' products. Stephenson also talks about the wider implications of sustainability for the industry, with advice for companies small and large on how to begin taking strategic action against climate change in 2022.

Health Ad Campaigns

UK’s EM Pharma Expands OTC Portfolio With Natural Anti-Viral Nasal Spray

Brits worried about contracting cold and flu viruses can now turn to EM Pharma's natural Nasofed nasal spray, which the firm says may also fight novel coronaviruses like COVID-19.

United Kingdom Health

Bayer Celebrates Rennie’s 90th Birthday With ‘Flirty’ UK Digital Marketing Campaign

Bayer Consumer Health celebrates heartburn brand Rennie's 90th birthday in the UK with a digital marketing campaign, including a competition for consumers to win a night out at a top British restaurant.

United Kingdom Health
See All

Latest From Ad Complaints & Health

PLx Will More Prominently Disclose ‘Clinically Shown’ Claim Refers To Vazalore 325-mg Aspirin

BBB National Programs’ appeals panel agrees with National Advertising Division that PLx should modify TV ad to clearly and conspicuously disclose that “clinically shown to cause fewer ulcers than plain aspirin” refers to Vazalore 325 mg and not 81-mg dose.

Ad Complaints Enforcement

Floss By Any Other Name Would Sell In Same Category – BBB National Programs Appeals Panel

NARB panel concluded #1 claims challenged by Oral-B floss products marketer P&G aren’t supported by acceptable evidence that the type of product the claim referenced – flossers  – “is recognized as a consumer-relevant category."

OTC Devices Ad Complaints

US 2021 Consumer Health Fraud Headaches Include Securities Scam By ‘Fast-Acting Aspirin’ Firm

FDA worked on investigations with US Attorneys’ offices and other federal agencies of unlawful sales of supplements promoted to prevent or treat COVID-19 as well as other diseases and health conditions and of prescription drugs offered OTC for muscle growth or sexual enhancement.

Consumer Coronavirus COVID-19
See All
UsernamePublicRestriction

Register